<unk>  is a tryptophan hydroxylase inhibitor that is FDA approved for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.   Common adverse reactions include nausea, headache, increased GGT, depression, flatulence, decreased appetite, peripheral edema, and pyrexia.
Telotristat ethyl
Crofelemer
Cevimeline
Cetiedil
Triptorelin pamoate
Perflenapent
Fasudil
Ranpirnase